
“neu REFIX ” potentials in Duchenne Muscular Dystrophy will be presented at MENA Rare Diseases Conference in UAE
“neu REFIX ” potentials in Duchenne Muscular Dystrophy will be presented at Congress held in UAE

“neu REFIX ” potentials in Duchenne Muscular Dystrophy will be presented at Congress held in UAE

“Nichi Glucan” and “Nichi BRITE” potentials will be presented at an academic conference in Osaka, Japan

A curiosity driven sojourn, across disciplines in science, led to the discovery of a safe adjuvant hidden in a beta glucan giving hope to patients with muscular dystrophy; A story of ZeitenWende all along, blessed with good people, hopefully a modest contribution to humanity by connecting the dots.

Published in Scientific Reports, a nature portfolio journal 15 November 2023 Significant reduction of muscle f

Edogawa NICHE Prize 2020 lecture by Dr. John Craig Venter, geneticist and a pioneer in human genome research in Toronto

Dr John Craig Venter to deliver the lecture in UHN Ajmera Transplant Center in University of Toronto

Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster

Nichi BRITE Beta glucans yileding clinically encouraging outcome in a trial was presented in the webinar that commemorated World Parkinsons Day held on the 10th April 2023

Neurology Live, a clinical neurologists focused media portal has published GN Corporation’s presentation at the MDA on the Clinical trial results of Neu REFIX in Duchenne Muscular Dystrophy
Cliny PEG Gastrostomy kits of Create Medic launched in India by Medinippon, GNCorp sister company 11Aug2023 Ja
Japanese scientists, research collaborators to Nichi-in Centre for Regenerative Medicine
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome